Geode Capital Management
CNTB icon

Geode Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Geode Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$264K Sell
240,173
-17,281
-7% -$35.3K ﹤0.01% 3780
2026
Q2 		$613K Buy
257,454
+225,325
+701% +$546K ﹤0.01% 3526
2026
Q1 		$84.2K Buy
32,129
+8,809
+38% +$23K ﹤0.01% 4174
2025
Q4 		$65.8K Hold
23,320
– – ﹤0.01% 4187
2025
Q3 		$34.5K Hold
23,320
– – ﹤0.01% 4361
2025
Q2 		$23.3K Sell
23,320
-4,641
-17% -$3.7K ﹤0.01% 4341
2025
Q1 		$15.4K Hold
27,961
– – ﹤0.01% 4396
2024
Q4 		$38.6K Hold
27,961
– – ﹤0.01% 4283
2024
Q3 		$39.7K Hold
27,961
– – ﹤0.01% 4306
2024
Q2 		$42.5K Hold
27,961
– – ﹤0.01% 4313
2024
Q1 		$48.7K Hold
27,961
– – ﹤0.01% 4329
2023
Q4 		$33K Buy
27,961
+8,929
+47% +$10.6K ﹤0.01% 4439
2023
Q3 		$14.8K Hold
19,032
– – ﹤0.01% 4672
2023
Q2 		$21.1K Hold
19,032
– – ﹤0.01% 4652
2023
Q1 		$19K Hold
19,032
– – ﹤0.01% 4707
2022
Q4 		$16K Hold
19,032
– – ﹤0.01% 4791
2022
Q3 		$24K Hold
19,032
– – ﹤0.01% 4889
2022
Q2 		$16K Hold
19,032
– – ﹤0.01% 4952
2022
Q1 		$57K Buy
+19,032
New +$80.3K ﹤0.01% 4783

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Quinn Opportunity Partners
Quinn Opportunity Partners Charlottesville, Virginia $1.85B AUM 1.27% 1-Year Est. Return
DMKJ
David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Geode Capital Management's CNTB Position: Q3 2026 in Review

Geode Capital Management reduced its Connect Biopharma Holdings (CNTB) stake by 6.7% in Q3 2026, selling an estimated $35.3K and leaving 240,173 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Geode Capital Management first reported a position in CNTB in Q1 2022 and has held it in 19 quarters since. The position peaked at $613K in Q2 2026. 29 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

  • Geode Capital Management held 240,173 shares of Connect Biopharma Holdings worth $264K as of Q3 2026.
  • Geode Capital Management sold 17,281 Connect Biopharma Holdings shares in Q3 2026, an estimated $35.3K.
  • Connect Biopharma Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3780 holding.
  • Geode Capital Management first reported a position in Connect Biopharma Holdings in Q1 2022 and has held it in 19 quarters since.
  • Geode Capital Management's Connect Biopharma Holdings position peaked at $613K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.